The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling
Juncheng Wei(Chinese University of Hong Kong), Fuchu He(Beijing University of Technology), Yanzhi Yuan(Beijing Proteome Research Center), Xiaoming Yang(University of North Carolina at Chapel Hill), Chaozhi Jin(Beijing Proteome Research Center), Min Wang(Central South University), Jian Wang(Beijing Proteome Research Center), Yang Li(Ministry of Education of the People's Republic of China), Ling Leng(Tianjin University of Traditional Chinese Medicine), Qiu Xiao(Beijing Radiation Center), Chao Wei(Ningbo University)
Cited by 33
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Outcome over seven years of healthy adults with and without subjective cognitive impairment
|Alzheimer s & Dementia|2010|582
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
|Cell Death and Differentiation|2019|582